The category's flagship format — where strain identity (LGG, BB-12, HN019) and delivery technology separate premium from commodity. We quote both acid-resistant encapsulation and spore-form options.
Tropical climates kill cold-chain probiotics — ambient-stable sachets own that map. Southeast Asia is the natural market and our stability data is built for exactly those conditions.
2026's next-gen direction (Vitaquest) — dead-but-functional cultures with zero CFU-count anxiety, zero cold chain and a genuine innovation story. The easiest "new generation" upgrade pitch to existing probiotic buyers.
The fertilizer half of the microbiome story — no live-culture logistics at all, indefinite shelf life, and a natural meal-replacement crossover. The steadiest margin in the track.
Only heat-tolerant strains survive a gummy matrix — that's the technical bar, and meeting it is what keeps your CFU claim honest. The US young-adult format of choice.
The no-bacteria alternative for gut shelves — enzyme activity units (not CFU) define quality, which makes claims simpler and stability trivial. Strong with the lactose-intolerant audience.
CFU counts must hold through shelf life (not "at manufacture"), and strains need traceable designations (LGG, BB-12…). Heat-sensitive strains should never be forced into gummies or hot-fill formats. Our certificates are written for the auditor, not the brochure — that's why our probiotic repeat rates survive retail audits.
Send your target market and dosage form — we'll come back with a formula outline, sample timeline and indicative pricing, usually the same business day.
